Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization

Alzheimer’s disease (AD) is a neurodegenerative disorder associated with marked oxidative stress at the level of the brain. Recent studies indicate that increasing the antioxidant capacity could represent a very promising therapeutic strategy for AD treatment. Astaxanthin (AST), a powerful natural a...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Nanomaterials (Basel)
Prif Awduron: Santonocito, Debora, Raciti, Giuseppina, Campisi, Agata, Sposito, Giovanni, Panico, Annamaria, Siciliano, Edy Angela, Sarpietro, Maria Grazia, Damiani, Elisabetta, Puglia, Carmelo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7913486/
https://ncbi.nlm.nih.gov/pubmed/33546352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nano11020391
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg